Chugai Pharmaceutical Co., Ltd.

4519.T
Drug Manufacturers - General
2026/02/17 Updated
Market Cap: $99.9B (¥15.3T)
Stock Price: $60.70 (¥9,282)
Exchange Rate: 1 USD = ¥152.91

Notice Regarding Dividend from Surplus

The fiscal year-end dividend for the term ending December 2025 is 147 yen per share (ordinary dividend 72 yen, 100th anniversary commemorative dividend 75 yen), raising the annual dividend to 272 yen. The total dividend amount is 241.92 billion yen, with an effective date of March 27, 2026.

Importance:
Page Updated: January 29, 2026
IR Disclosure Date: January 29, 2026

Key Figures

  • Year-end Dividend per Share: 147 yen 00 sen (ordinary dividend 72 yen, 100th anniversary commemorative dividend 75 yen)
  • Annual Dividend per Share: 272 yen 00 sen (ordinary dividend 122 yen, 100th anniversary commemorative dividend 150 yen)
  • Total Dividend Amount: 241.92 billion yen

AI要約

Dividend Overview

Chugai Pharmaceutical Co., Ltd. has resolved a year-end dividend of 147 yen per share (ordinary dividend 72 yen, 100th anniversary commemorative dividend 75 yen) with the record date set on December 31, 2025, to be proposed at the 115th Annual General Meeting of Shareholders scheduled for March 26, 2026. This brings the annual dividend to 272 yen, with a total dividend payout of 241.92 billion yen. The dividend source is retained earnings.

Dividend Policy and Future Outlook

The company aims for a stable dividend policy targeting a dividend payout ratio averaging 45% relative to Core EPS. In fiscal 2025, Core net income marked its ninth consecutive year of growth, with Core EPS increasing 13.6% year-over-year. Based on this, the payout ratio reached 99.3% (five-year average 54.9%). The dividend forecast for 2026 is 132 yen annually (including an interim dividend of 66 yen), with an expected Core dividend payout ratio of 44.7% (five-year average 54.7%).

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.